Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1718758

registered interest
date	16/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help improve (a) research into treatments for and (b) (i) emotional and (ii) financial support for people living with pancreatic cancer.
tabling member constituency	Putney
tabling member printed	Fleur Anderson
uin	26771
answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>Research is crucial in tackling cancer, which is why the Department invests £1.3 billion per year in health research, through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £121.8 million in 2022/23, and the NIHR spends more on cancer than any other disease group. <br> <br> The NIHR funded nine research projects on pancreatic cancer since 2018/19, with a committed funding value of £4.3 million. The NIHR continues to welcome funding applications for research into any aspect of human health, including pancreatic cancer. Applications are subject to peer review and judged in open competition. <br> <br> The NIHR also supports delivery of research into pancreatic cancer in the health and care system, funded by research funding partners in the charity and public sectors. Since 2018/19 the NIHR supported 73 clinical research studies through the Clinical Research Network. <br> <br> Additionally, NIHR Biomedical Research Centres (BRC) and NIHR Clinical Research Facilities spent a further £6.5 million between 2018/19 and 2022/23, supporting an annual portfolio of approximately 85 early clinical studies into pancreatic cancer. NIHR BRCs are collaborations between world-leading universities and National Health Service organisations, that bring together academics and clinicians to translate discoveries from basic or discovery science into clinical research. <br> <br> For emotional and financial support, patient feedback is monitored through the National Cancer Patient Experience Survey, with the latest results showing an overall experience of 8.88 out of 10. In areas such as support for health and wellbeing, and information on financial help, results were positive but showed room for improvement. NHS England continues to support trusts to take action to improve cancer patient support.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/05/2024 08:21:01 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4788 label Biography information for Fleur Anderson

1718766

registered interest
date	16/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential merits of offering breast cancer screening to women going through early menopause.
tabling member constituency	Putney
tabling member printed	Fleur Anderson
uin	26776
answer	answer is ministerial correction date of answer 21/05/2024 answer text <p>The UK National Screening Committee (UK NSC) currently recommends that all women aged 50 to 71 years old are invited for a breast screening every three years. The AgeX trial is looking at the impact of increasing or decreasing the screening age for breast screening, and the UK NSC will review its findings when they are available.</p><p>The UK NSC can be alerted to any new published peer reviewed evidence which may suggest the case for a new screening programme, or changes to an existing one. Proposals can be submitted via the UK NSC’s annual call in July 2024, which is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/uk-nsc-annual-call-submitting-a-screening-proposal/uk-nsc-annual-call-how-to-submit-a-proposal#:~:text=To%20submit%20a%20proposal%20for,your%20name" target="_blank">https://www.gov.uk/government/publications/uk-nsc-annual-call-submitting-a-screening-proposal/uk-nsc-annual-call-how-to-submit-a-proposal#:~:text=To%20submit%20a%20proposal%20for,your%20name</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 21/05/2024 16:51:28 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4788 label Biography information for Fleur Anderson

1718802

registered interest
date	16/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bipolar Disorder: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department have taken to reduce the time taken from initial presentation of symptoms to diagnosis of bipolar disorder.
tabling member constituency	Leeds North West
tabling member printed	Alex Sobel
uin	26719
answer	answer is ministerial correction date of answer 22/05/2024 answer text <p>We’re set to reach nearly £1 billion of additional funding invested by 2023/24, compared to 2018/19, to transform community mental health services. In 2022/23, 288,000 people with severe mental illness, including bipolar disorder, accessed support through new integrated models of community care.</p><p>The funding aims to increase access to high quality care and transform care pathways for people with severe mental illness, including bipolar disorder, through: greater integration of primary and community services, to provide care in the community driven by the needs of individuals, rather than based solely on diagnoses; physical health checks; and Individual Placement and Support schemes, as well as Early Intervention in Psychosis services.</p><p>NHS England is also working on implementing new access and waiting time standards for mental health services, including one for adults with bi-polar disorder or similar, to start to receive community-based mental health care within four weeks of referral.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 22/05/2024 09:28:15 answering member 4492 label Biography information for Maria Caulfield
tabling member	4658 label Biography information for Alex Sobel

1718814

registered interest
date	16/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: Standards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 February 2023 to Question 142657 on Mental Health Services: Children and Young People, what progress has been made on work to (a) establish the feasibility and associated risks of introducing new mental health waiting time standards for (i) adult's and (ii) children and young people’s community-based mental health services and (b) support the development of a baseline position for waiting times.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	26668
answer	answer is ministerial correction date of answer 22/05/2024 answer text <p>NHS England will publish new core community all-age mental health waiting time metrics from autumn 2024, which will encompass activity data from April 2024. It will cover the percentage of patients receiving meaningful help within four weeks of referral to community mental health services. Once published, NHS England will focus on improving data quality, including ensuring appropriate Systematised Nomenclature of Medicine data is flowed to show when patients are receiving meaningful help. Improved data quality within community mental health services will provide greater insights into the frequency and types of therapeutic provision.</p><p>The publication of the new community waiting times metrics is expected to increase transparency and local accountability on waiting times for community mental health services. Furthermore, NHS England expect that publication of the data will improve the quality of the data, so that the Department and NHS England will be in a better position to assess the costs and benefits of introducing performance standards against these metrics.</p><p>Systems have also been asked to focus on reducing long waits in community mental health services and to develop local plans to support this, including by improving data quality. We will work with systems to develop an agreed baseline and improvement trajectories for waits over 104 weeks in autumn 2024, as referenced in NHS England’s 2024/25 Operational Planning Guidance.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 22/05/2024 09:35:04 answering member 4492 label Biography information for Maria Caulfield
tabling member	3930 label Biography information for Caroline Lucas

1718862

registered interest
date	16/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Payments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many responses were received to her Department's consultation entitled The disclosure of industry payments to the healthcare sector, which closed on 16 October 2023; and what her planned timetable is to respond to that consultation.
tabling member constituency	Shipley
tabling member printed	Sir Philip Davies
uin	26667
answer	answer is ministerial correction date of answer 21/05/2024 answer text <p>The Department launched a United Kingdom-wide public consultation on 4 September 2023 on the disclosure of industry payments to the healthcare sector. The consultation sought views on the possible introduction of regulations through new secondary legislation, as well as views on alternative options to regulations. There were 603 responses to the consultation. The Department is analysing the responses, and the Government’s response will be published in due course.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 21/05/2024 16:47:43 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1565 label Biography information for Sir Philip Davies

1718901

registered interest
date	16/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Fractures: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many patients were referred to the Fracture Liaison Service with fragility fractures in each of the last five years; and what proportion of those patients were women over the age of 50.
tabling member constituency	Swansea East
tabling member printed	Carolyn Harris
uin	26702
answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>While NHS England does not hold this information centrally, data in relation to the Fracture Liaison Services (FLS) can be found in the FLS-Database Annual reports. The 2024 report, which includes data in relation to gender, is available at the following link:</p><p><a href="https://www.hqip.org.uk/wp-content/uploads/2024/02/Ref-419-FLS-DB-2024-annual-report-1.pdf" target="_blank">https://www.hqip.org.uk/wp-content/uploads/2024/02/Ref-419-FLS-DB-2024-annual-report-1.pdf</a></p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 26703 question first answered 23/05/2024 08:17:07 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4480 label Biography information for Carolyn Harris

1718902

registered interest
date	16/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Fractures: Women
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many and what proportion of the women over the age of 50 that were referred to the Fracture Liaison Service with fragility fractures were (a) taking hormone replacement therapy (HRT) prior to their first fragility fracture and (b) prescribed HRT as part of their treatment after their first fragility fracture in each of the last five years.
tabling member constituency	Swansea East
tabling member printed	Carolyn Harris
uin	26703
answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>While NHS England does not hold this information centrally, data in relation to the Fracture Liaison Services (FLS) can be found in the FLS-Database Annual reports. The 2024 report, which includes data in relation to gender, is available at the following link:</p><p><a href="https://www.hqip.org.uk/wp-content/uploads/2024/02/Ref-419-FLS-DB-2024-annual-report-1.pdf" target="_blank">https://www.hqip.org.uk/wp-content/uploads/2024/02/Ref-419-FLS-DB-2024-annual-report-1.pdf</a></p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 26702 question first answered 23/05/2024 08:17:07 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4480 label Biography information for Carolyn Harris

1718234

registered interest
date	15/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Vaccine Damage Payment Scheme: Reviews
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the terms of reference are for her Department's review of the vaccine damage compensation scheme; which body is responsible for undertaking the review; and what estimate she has made of when the review will be completed.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	26322
answer	answer is ministerial correction date of answer 22/05/2024 answer text <p>All routine policy, including the Vaccine Damage Payment Scheme (VDPS), is reviewed on a regular basis. My Rt hon. Friend, the Secretary of State for Health and Social Care is currently looking into aspects of the scheme, following recent meetings with interested stakeholders.</p><p>Separately, work is underway with the scheme’s administrator, the NHS Business Service Authority, to review processes and make administrative changes, to improve the scheme within the current legislative framework. Formal consideration of whether any reforms to the VDPS are necessary will form part of Module 4 of the COVID-19 Inquiry, chaired by the Rt Hon Baroness Heather Carol Hallett DBE.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 26628 26635 26636 question first answered 22/05/2024 10:43:11 answering member 4492 label Biography information for Maria Caulfield previous answer version 35275 answering member constituency Lewes answering member printed Maria Caulfield answering member 4492 label Biography information for Maria Caulfield
tabling member	242 label Biography information for Sir Christopher Chope

1718235

registered interest
date	15/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: Private Sector
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the (a) prevalence of the use of, (b) adequacy of the standards of service provided by and (c) potential impact on patient outcomes of the use of the private sector in the provision of mental health services in the NHS; and what steps she has taken to help ensure compliance by the private sector with the Code of Practice: Mental Health Act 1983.
tabling member constituency	Halton
tabling member printed	Derek Twigg
uin	26363
answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>No such specific assessment has been made. Private companies have always played a role in the National Health Service, and patients should expect a safe and good quality service regardless of whether their care is delivered by private sector or public sector providers. Local integrated care boards are responsible for commissioning health and care services for their local populations, in line with the standards set out in the NHS Standard Contract.</p><p>The Care Quality Commission is the independent regulator of health and care services. All providers of regulated activities, including those in the private sector, must register with the Care Quality Commission, and follow a set of fundamental standards of safety and quality, below which care should never fall.</p><p>The Care Quality Commission also has a duty under the Mental Health Act 1983 to monitor how services exercise their powers and discharge their duties under the act when patients are detained in hospital or are subject to community treatment orders or guardianship.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 20/05/2024 17:05:21 answering member 4492 label Biography information for Maria Caulfield
tabling member	429 label Biography information for Derek Twigg

1718277

registered interest
date	15/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that patients taking pancreatic enzymes continue to receive them.
tabling member constituency	Walthamstow
tabling member printed	Stella Creasy
uin	26452
answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>We are aware of supply issues with three pancreatic enzyme replacement therapies: Creon 10000 gastro-resistant capsules; Creon 25000 gastro-resistant capsules; and Nutrizym 22 gastro-resistant capsules. We understand that these are due to limited availability of active pharmaceutical ingredients, and manufacturing constraints in producing the volumes required to meet demand. The Department has issued guidance to healthcare professionals regarding treatment of patients while there is a disruption to the supply of these pancreatic enzyme replacement therapies. We are having regular conversations with the suppliers of these products, to ask that they expedite deliveries and increase production forecasts, and to confirm that they are taking action to address the root causes of the issues, to ensure continuity of supply. We are also working with specialist importers to source unlicensed imports from abroad.</p><p>Whilst we can’t always prevent supply issues, we have a range of well-established tools and processes to mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols, and issuing National Health Service communications to provide management advice and information on the issue to healthcare professionals, so they can advise and support their patients.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 20/05/2024 16:55:17 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4088 label Biography information for Stella Creasy